The FLT3 Tyrosine Kinase in Leukemia : Deciphering the Downstream Signaling Events and Drug-Escape Mechanisms
Acute myeloid leukemia (AML) is a severe disease, which originates in blood-forming cells. Although major advances in understanding the biology of AML, the majority of patients eventually succumb to the disease. The tyrosine kinase receptor FLT3 has become an attractive therapeutic target AML for tw...
Main Author: | Nordigården, Amanda |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Linköpings universitet, Experimentell hematologi
2013
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-88202 http://nbn-resolving.de/urn:isbn:978-91-7519-685-5 |
Similar Items
-
BCR-ABL1A TYROSINE KINASE ASSOCIATED WITH CHRONIC MYELOID LEUKEMIA : Calculation of solvation energiesand electrostatics by APBS and prediction of 2D and 3D structureby homology protein modeling
by: Tiltu Klintborg, Anna
Published: (2021) -
On mechanisms of drug resistance in acute myeloid leukemia
by: Prenkert, Malin
Published: (2010) -
Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling.
by: Julhash U Kazi, et al.
Published: (2012-01-01) -
Adverse events induced by first immunization in extremely premature infants
by: Sundman Rosén, Linnea
Published: (2016) -
Notch signaling pathways inthe obese mouse
by: Petersson, Johan
Published: (2017)